PHARMANUTRA SPA (PHN.MI) Stock Price, Quote, News and Overview
BIT:PHN - Borsa Italiana Milan - IT0005274094 - Common Stock - Currency: EUR
PHN.MI Quote, Performance and Key Statistics
PHARMANUTRA SPA
BIT:PHN (2/4/2025, 3:31:42 PM)
51.9
-0.1 (-0.19%)
The current stock price of PHN.MI is 51.9 EUR. In the past month the price decreased by -3.53%. In the past year, price decreased by -14.78%.
PHN.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LOR.DE | L'OREAL | 28.45 | 187.44B | ||
| OR.PA | L'OREAL | 28.44 | 187.36B | ||
| UNA.AS | UNILEVER PLC | 20.99 | 137.07B | ||
| UNVB.DE | UNILEVER PLC | 20.92 | 136.62B | ||
| BEI.DE | BEIERSDORF AG | 38.94 | 31.48B | ||
| H6D0.DE | HALEON PLC | 22.88 | 20.69B | ||
| COTY.PA | COTY INC-CL A | 16.32 | 5.82B | ||
| ITP.PA | INTERPARFUMS SA | 27.58 | 3.25B | ||
| ICOS.MI | INTERCOS SPA | 28.55 | 1.29B | ||
| ONTEX.BR | ONTEX GROUP NV | 13.44 | 653.04M | ||
| JBOG.PA | JACQUES BOGART | 21.69 | 88.44M |
Related stock screener links
About PHN.MI
Company Profile
Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa and currently employs 105 full-time employees. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.
Company Info
PHARMANUTRA SPA
Via delle Lenze n. 216/B
Pisa PISA IT
Employees: 112
Company Website: https://www.pharmanutra.it/
Investor Relations: http://pharmanutra.it/en/financial-statements-and-reports/
Phone: 390507846500
PHN.MI FAQ
What is the stock price of PHN.MI?
The current stock price of PHN.MI is 51.9 EUR.
What is the symbol for PHARMANUTRA SPA stock?
The exchange symbol of PHARMANUTRA SPA is PHN and it is listed on the Borsa Italiana Milan exchange.
On which exchange is PHN.MI stock listed?
PHN.MI stock is listed on the Borsa Italiana Milan exchange.
Is PHN.MI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PHN.MI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PHN.MI.
Does PHN.MI stock pay dividends?
PHN.MI has a dividend yield of 1.67%. The yearly dividend amount is currently 0.8.
What is the Price/Earnings (PE) ratio of PHN.MI?
The PE ratio for PHN.MI is 39.02. This is based on the reported non-GAAP earnings per share of 1.33 and the current share price of 51.9 EUR.
PHN.MI Technical Analysis
PHN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI. PHN.MI gets an excellent profitability rating and is at the same time showing great financial health properties.
PHN.MI Financial Highlights
Over the last trailing twelve months PHN.MI reported a non-GAAP Earnings per Share(EPS) of 1.33. The EPS decreased by -14.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.9% | ||
| ROA | 17.55% | ||
| ROE | 35.81% | ||
| Debt/Equity | 0.42 |
PHN.MI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PHN.MI. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 43.02% and a revenue growth 15.93% for PHN.MI